Trade group tells FDA that semaglu­tide is not too 'com­plex' for com­pound­ing

The Al­liance for Phar­ma­cy Com­pound­ing told the FDA last week that No­vo Nordisk’s weight loss med­i­cine semaglu­tide is not too dif­fi­cult to com­pound, push­ing back …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER